EUVIMEDEUVIMED entdecken
Multizentrische Studie

Predictors of recurrent restenosis after repeat drug‐coated balloon therapy for drug‐coated balloon restenosis in femoropopliteal lesions: Results of the RECURRENCE study

Takashi Yanagiuchi iD, Kuniyoshi Fukai iD, Koji Sogabe, Yoshihiro Iwasaki, Keita Hirano, Taku Kato, Hirokazu Yokoi, Kan Zen, Satoaki Matoba

Catheterization and Cardiovascular Interventions · 2024

DOI: 10.1002/ccd.31245 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Catheterization and Cardiovascular Interventions, 2024. Verfasst von Takashi Yanagiuchi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Rakuwakai Otowa Hospital, Kyoto, Japan. Hauptthemen laut MEDLINE: Femoral Artery, Peripheral Arterial Disease, Popliteal Artery, Recurrence. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Despite the widespread use of drug‐coated balloons (DCBs) for femoropopliteal (FP) lesions, there is still no consensus on treatment strategies for DCB restenosis. This study aimed to determine the risk factors for recurrent restenosis after repeat DCB therapy for DCB restenosis in FP lesions.

Methods

This multicenter retrospective study assessed 1176 consecutive limbs in 860 patients who successfully received initial DCB therapy for FP lesions at four cardiovascular centers between May 2018 and December 2022. Among these patients, 118 consecutive limbs of 104 patients treated via repeat DCB for primary DCB restenosis were enrolled.

Results

The Kaplan–Meier estimate of freedom from recurrent restenosis was 74.6% at 1 year. Cox proportional hazard multivariate analysis revealed that recurrent restenosis was independently associated with the time from initial DCB to primary restenosis (hazard ratio [HR], 0.85; 95% confidence interval [CI], 0.79–0.92; p < 0.001), history of ≥2 endovascular therapies (EVTs) (HR, 3.11; 95%CI, 1.36–7.12; p = 0.007), and PACSS grade 3 or 4 (HR, 2.76; 95%CI, 1.15–6.63; p = 0.023). Furthermore, receiver operating characteristic curve analysis showed that the cutoff value of the time from initial DCB to primary restenosis to prevent recurrent restenosis was 12.6 months, with an area under the curve of 0.841 ( p < 0.001).

Conclusion

Repeat DCB therapy for DCB restenosis might be an acceptable strategy, particularly for restenosis that occurred more than 12.6 months after initial DCB, given the rate of freedom from recurrent restenosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Femoral ArteryPeripheral Arterial DiseasePopliteal ArteryRecurrenceCoated Materials, BiocompatibleAngioplasty, BalloonVascular Access DevicesVascular PatencyCardiovascular AgentsRetreatmentHumansMaleRetrospective StudiesFemaleAgedRisk FactorsTime FactorsMiddle AgedRisk AssessmentAged, 80 and overConstriction, PathologicTreatment Outcome

Stichwörter der Autor:innen

drug‐coated balloonendovascular therapyfemoropopliteal segmentrestenosis

Substanzen

Coated Materials, BiocompatibleCardiovascular Agents

Autor:innen und Institutionen

  • Department of Cardiology, Rakuwakai Otowa Hospital, Kyoto, Japan.
  • Department of Cardiovascular Medicine, Omihachiman Community Medical Center, Shiga, Japan.
  • Department of Cardiovascular Medicine, Kyoto Okamoto Memorial Hospital, Kyoto, Japan.
  • Cardiovascular Center, Kyoto Katsura Hospital, Kyoto, Japan.
  • Department of Nephrology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Department of Cardiology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan.

ORCID-Profile: Takashi Yanagiuchi, Kuniyoshi Fukai

Zitieren

APA

Yanagiuchi, T., Fukai, K., Sogabe, K., Iwasaki, Y., Hirano, K., Kato, T., Yokoi, H., Zen, K., & Matoba, S. (2024). Predictors of recurrent restenosis after repeat drug‐coated balloon therapy for drug‐coated balloon restenosis in femoropopliteal lesions: Results of the RECURRENCE study. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.31245

Vancouver

Yanagiuchi T, Fukai K, Sogabe K, Iwasaki Y, Hirano K, Kato T, et al. Predictors of recurrent restenosis after repeat drug‐coated balloon therapy for drug‐coated balloon restenosis in femoropopliteal lesions: Results of the RECURRENCE study. Catheterization and Cardiovascular Interventions. 2024. doi:10.1002/ccd.31245

BibTeX
@article{Yanagiuchi2024,
  author = {Yanagiuchi, Takashi and Fukai, Kuniyoshi and Sogabe, Koji and Iwasaki, Yoshihiro and Hirano, Keita and Kato, Taku and Yokoi, Hirokazu and Zen, Kan and Matoba, Satoaki},
  title = {Predictors of recurrent restenosis after repeat drug‐coated balloon therapy for drug‐coated balloon restenosis in femoropopliteal lesions: Results of the RECURRENCE study},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2024},
  doi = {10.1002/ccd.31245}
}
Kostenlos starten →